비알코올성 지방간염 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00009653
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 178
Buy Now

비알코올성 지방간염(NASH) 시장은 2021년 16억 3,192만 달러에서 2028년 242억 6,681만 달러로 성장할 것으로 예상된다. 2021년부터 2028년까지 연평균 성장률(CAGR) 47.1%를 기록할 것으로 예상됩니다.

비알코올성 지방간 질환(NAFLD)의 경우 간에 지방이 축적됩니다. 비알코올성 지방간(NAFL)과 비알코올성 지방간염(NASH)은 NAFLD의 유형입니다. 지방 축적이 염증과 손상을 일으키면 NASH가 발생하여 간에 흉터가 생길 수 있습니다. 간의 흉터는 간경변이라고 불리는 잠재적으로 생명을 위협하는 상태입니다.

이 보고서는 시장 동향, 기술 발전, 시장 역학 등 다양한 매개변수를 강조하면서 비알코올성 지방간염(NASH) 시장에 대한 통찰력과 심층 분석을 제공합니다. 또한 전 세계 주요 시장 플레이어의 경쟁 환경 분석을 제공합니다. 또한 여기에는 COVID-19 전염병이 모든 지역의 시장에 미치는 영향이 포함됩니다. 코로나19 팬데믹(세계적 대유행)은 전 세계 여러 나라의 사회경제적 상황을 혼란에 빠뜨렸습니다. 북미에서는 미국이 코로나19 팬데믹으로 인해 큰 타격을 입었습니다. 코로나19 환자의 아미노전이효소 증가 및 고빌리루빈혈증 형태의 간 손상은 기존의 간 질환을 포함한 몇 가지 요인에 기인할 수 있습니다. 이들 환자의 비알코올성 지방간 질환(NAFLD)과 NASH의 동반 질환으로 인해 심각한 형태의 간 손상이 발생하기 쉽습니다. 전 세계적으로 NAFLD의 유병률이 높다는 점을 감안할 때, 동반 질환의 역할, 질병 진행 및 코로나 중증도를 포함하는 그러한 환자의 코로나19 결과를 인식하는 것이 훨씬 중요합니다. NASH/NAFLD가 아닌 섬유증의 존재는 코로나19 환자의 더 나쁜 임상 결과 및 더 높은 사망률과 관련이 있습니다.

COVID-19가 동반 질환 환자 집단에 미치는 영향 당뇨병, 비만, 지방간 질환 및 NASH 환자를 포함한 사람들은 환자에게 최적의 치료를 제공해야 할 필요성을 촉발시켰습니다. 글로벌 간 연구소(Global Liver Institute)는 전 세계의 연구자 및 혁신가들과 협력하여 이 전염병에 대한 강력한 대응을 신속하게 평가하고 알리는 데 최선을 다하고 있습니다. NAFLD 및 NASH 퇴치를 중심으로 한 연구에서는 체중 문제와 예상되는 관계가 뚜렷하다는 것을 나타냅니다. 따라서 NASH 발병률이 높을수록 고급 진단 및 치료가 필요하며 이는 시장의 연구 개발을 촉진합니다. 따라서 코로나19 위기는 비알코올성 지방간염(NASH) 시장 성장을 촉진했습니다.

  

전략적 통찰력

비알코올성 지방간염(NASH) 시장의 수익성이 높은 지역

시장 통찰력

NASH 드라이브 시장 성장에 대한 인식 제고를 위한 이니셔티브 증가

NASH는 잘 인식되지 않는 상태입니다. 구조화된 의뢰 경로와 조기 발견을 위해서는 일반 대중과 주치의(PCP) 사이에서 이 질병에 대한 더 큰 인식을 구축하는 것이 필수적입니다. 의뢰 및 환자 인식 캠페인을 위한 명확한 환자 경로를 설정함으로써 더 많은 개인을 식별하고 추가 평가를 위해 전문가에게 보낼 수 있습니다. NASH에 대한 인식을 높이기 위해 NASH 교육 프로그램은 2018년 6월 12일에 "국제 NASH의 날"로 공립 교육 캠페인을 시작하여 NAFLD와 그보다 발전된 형태인 NASH에 대한 인식을 제고했으며 이는 약 1억 1500만 명 이상에 영향을 미칩니다. 사람들.

NASH 전염병에 대한 노출과 인식 제고를 목표로 하는 디지털 플랫폼인 NASH 24X7은 2019년 국제 NASH의 날을 맞아 HCP 지원, 환자 인식 제고를 통해 몇 가지 조치를 취했습니다. , 언론/TV 공개 프로그램. 이날 NASH 24X7의 NASH Crusaders는 인식을 높이기 위해 인도 전역의 최고 의료 서비스 제공자(HCP), 특히 위장병 전문의 및 간 전문의와 협력하여 많은 소규모 및 대규모 인식 및 amp; NAFLD/NASH 예방을 위한 건강한 생활 방식의 필요성을 강조하는 간 건강에 대한 교육 워크숍.

2020년 국제 NASH의 날을 맞아 American Liver Foundation은 글로벌 커뮤니티에 합류하여 다음을 수행했습니다. Allergan 재단의 지원으로 NASH에 대한 인식을 제고합니다. ALF(American Liver Foundation)는 현재 NASH 문자 메시지 프로그램을 시범 운영하고 있습니다. 이 프로그램에서는 사람들이 등록하여 10주 동안 매주 3개의 메시지를 받을 수 있습니다. 메시지는 NASH 리소스에 대한 하이퍼링크, 관련 사실, 대화형 퀴즈 및 일상적인 자기 관리를 위한 합리적인 지침으로 구성됩니다. ALF는 파일럿이 완료되고 평가되면 이 시스템을 일반 대중에게 공개할 예정입니다. 국제 NASH의 날을 맞아 글로벌 간 연구소(GLI)와 협력했으며, GLI 게시물과 국제 NASH의 날 페이지에 링크된 몇 가지 소셜 미디어 게시물을 공유했습니다.

이렇게 , NASH에 대한 인식을 제고하기 위한 이니셔티브가 증가하면서 비알코올성 지방간염(NASH) 시장이 주도되고 있습니다.

제품 기반 통찰력

기반 제품에 있어서 비알코올성 지방간염(NASH) 시장은 비타민 E와 피오글리타존, ocaliva, elafibranor, selonsertib & 세니크리비록(cenicriviroc) 등. 2021년에는 기타 부문이 시장에서 가장 큰 점유율을 차지했습니다. 더 셀론서팁 & 세니크리비록 부문은 예측 기간 동안 73.3%의 가장 빠른 CAGR을 기록할 것으로 예상됩니다.

제품별 장기 보존 솔루션 시장 – 2020년 및 2028년

애플리케이션 기반 통찰력

비알코올성 지방간염(NASH) 시장은 애플리케이션을 기준으로 치료와 진단으로 나누어집니다. 2021년에는 치료 부문이 시장에서 더 큰 점유율을 차지했습니다. 그러나 치료 부문은 예측 기간 동안 47.3%의 더 높은 CAGR을 기록할 것으로 예상됩니다.

판매 채널 기반 통찰력

기반 판매 채널에서 비알코올성 지방간염(NASH) 시장은 병원 약국, 소매 약국 및 온라인 제공업체로 분류됩니다. 2021년에는 소매 약국 부문이 시장에서 가장 큰 점유율을 차지했습니다. 또한, 소매 약국 부문은 2021~2028년에 47.2%의 가장 높은 CAGR을 기록할 것으로 예상됩니다.

비알코올성 지방간염(NASH) 시장 참여자는 유기농 전략을 채택합니다. 전 세계적으로 입지와 제품 포트폴리오를 확장하고 증가하는 수요를 충족하기 위한 제품 출시 및 확장 등이 있습니다.

지역별

기반 지리학적으로 비알코올성 지방간염(NASH) 시장은 북미(미국, 캐나다, 멕시코), 유럽(영국, 독일, 프랑스, 이탈리아, 스페인 및 기타 유럽), 아시아 태평양(중국, 일본)으로 분류됩니다. , 인도, 호주, 한국 및 기타 아시아 태평양 지역), 중동 및 아프리카(UAE, 사우디아라비아, 남아프리카공화국, 기타 중동 및 아프리카), 남부 및 아프리카 중앙 아메리카(브라질, 아르헨티나, 나머지 중남미).

회사 프로필

  • Genfit SA
  • One Way Liver, SL
  • BioPredictive SAS
  • Cadila Pharmaceuticals Ltd.
  • Prometheus Laboratories
  • Siemens Healthineers AG
  • Intercept Pharmaceuticals, Inc.
  • Novartis AG
  • Galmed Pharmaceuticals
  • Laboratory Corporation of America Holdings            
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is non-alcoholic steatohepatitis (NASH)?

Nonalcoholic fatty liver disease (NAFLD) is a condition in which fat builds up in your liver. Nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH) are types of NAFLD. Non-alcoholic steatohepatitis (NASH) is an advanced form of non-alcoholic fatty liver disease (NAFLD). NAFLD is caused by buildup of fat in the liver. When this buildup causes inflammation and damage, it is known as NASH, which can lead to scarring of the liver. Scarring of the liver is a potentially life-threatening condition called cirrhosis.

What are the driving factors for the non-alcoholic steatohepatitis (NASH) market across the globe?

Key factors that are driving the growth of this market are the rising prevalence of NASH and increasing initiatives for the awareness of NASH. Additionally, the growing clinical trials involving combination studies of drugs is likely to emerge as a significant future trend in the market during the forecast period.

What is the market CAGR value of the non-alcoholic steatohepatitis (NASH) market during the forecast period?

The CAGR value of the non-alcoholic steatohepatitis (NASH) market during the forecasted period of 2021–2028 is 47.1%.

Which product led the non-alcoholic steatohepatitis (NASH) market?

The product segment of the non-alcoholic steatohepatitis (NASH) market is segmented into vitamin E and pioglitazone, ocaliva, elafibranor, selonsertib & cenicriviroc, and others. In 2021, the others segment held the largest share of the market, by product. The selonsertib & cenicriviroc segment of the non-alcoholic steatohepatitis (NASH) market is expected to witness growth in its demand at the fastest CAGR of 73.3% from 2024 to 2028.

Which application held the largest share in the non-alcoholic steatohepatitis (NASH) market?

The treatment segment dominated the global non-alcoholic steatohepatitis (NASH) market and accounted for the largest market share of 84.90% in 2021.

Which sales channel held the largest share in the non-alcoholic steatohepatitis (NASH) market?

The retail pharmacy segment dominated the global non-alcoholic steatohepatitis (NASH) market and accounted for the largest market share of 61.39% in 2021.

Who are the key players in the non-alcoholic steatohepatitis (NASH) market?

The non-alcoholic steatohepatitis (NASH) market majorly consists of players such as Genfit SA; One Way Liver, S.L.; BioPredictive S.A.S.; Cadila Pharmaceuticals Ltd.; Prometheus Laboratories; Siemens Healthineers AG; Intercept Pharmaceuticals, Inc.; Novartis AG; Galmed Pharmaceuticals; and Laboratory Corporation of America Holdings amongst others.

Which are the top companies that hold the market share in non-alcoholic steatohepatitis (NASH) market?

Intercept Pharmaceuticals, Inc and Genfit SA are the top two companies that hold huge market shares in the non-alcoholic steatohepatitis (NASH) market.

Which region is expected to witness significant demand for the non-alcoholic steatohepatitis (NASH) market in the coming years?

North America held the largest market share for non-alcoholic steatohepatitis in 2021. The United States held the largest market in North America for non-alcoholic steatohepatitis, and the market is expected to grow due to increasing adoption of technological advancements and rising emphasis on improving treatment outcomes are projected to accelerate the growth of the non-alcoholic steatohepatitis market.

What is the COVID 19 impact on the non-alcoholic steatohepatitis (NASH) market in the coming years?

The presence of nonalcoholic fatty liver disease (NAFLD) and NASH in patients with COVID-19 is likely to cause them to be prone to severe forms of liver injury. Given the high prevalence of NAFLD worldwide, it's far critical to recognize the results of COVID-19 in such patients, which include the role of comorbidities, disease progression, and the severity of COVID-19. The presence of fibrosis rather than NASH/NAFLD is associated with worse clinical outcomes and higher mortality in COVID-19 patients. Additionally, there seems to be an increased likelihood of liver injury in NAFLD patients with COVID-19.
NASH had the strongest association with COVID-19 of all comorbid metabolic conditions, including hypertension and obesity. As the world keeps confronting the novel coronavirus pandemic, the impact of COVID-19 on specific patient populations, which includes people with diabetes, obesity, fatty liver disease, and NASH, has proven the need of providing actionable recommendations to clinicians and patients to offer optimal care and avoid needless deaths. The Global Liver Institute is committed to operating with researchers and innovators worldwide to evaluate and inform a strong response to this pandemic rapidly. As the push to combat NAFLD and NASH continues, research indicates that the anticipated relationship with weight problems is stark. Individuals with signs and symptoms of underlying fatty liver disease and NASH are at higher risk and infectious for longer for COVID-19. Therefore, COVID-19 is affected positively on the growth of the market.

The List of Companies - Non-Alcoholic Steatohepatitis (NASH) Market
  1. Genfit SA
  2. One Way Liver, S.L.
  3. BioPredictive S.A.S
  4. Cadila Pharmaceuticals Ltd.
  5. Prometheus Laboratories
  6. Siemens Healthineers AG
  7. Intercept Pharmaceuticals, Inc.
  8. Novartis AG
  9. Galmed Pharmaceuticals
  10. Laboratory Corporation of America Holdings

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports